JP Morgan Chase’s Erasca ERAS Stock Holding History

JP Morgan Chase’s Portfolio ERAS Stock Details ERAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.68M	Buy	+112,500	New	+$1.33M	﹤0.01%	4242

Other funds holding ERAS

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

JP Morgan Chase's ERAS Position: Q1 2026 in Review

JP Morgan Chase reduced its Erasca (ERAS) stake by 20% in Q1 2026, selling an estimated $2.7M and leaving 924,405 shares worth $13.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2395.

JP Morgan Chase first reported a position in ERAS in Q3 2021 and has held it in 19 quarters since. 225 funds tracked by Wall St. Rank hold ERAS as of Q1 2026.

JP Morgan Chase held 924,405 shares of Erasca worth $13.8M as of Q1 2026.
JP Morgan Chase sold 228,685 Erasca shares in Q1 2026, an estimated $2.7M.
Erasca made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #2395 holding.
JP Morgan Chase first reported a position in Erasca in Q3 2021 and has held it in 19 quarters since.
225 funds tracked by Wall St. Rank held Erasca as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.